Skip to main content

Month: April 2021

Onxeo to Present New Preclinical Data at AACR 2021

Confirming the effect of AsiDNA™ on resistance to KRAS inhibitors Introducing OX400, a new generation of PARP interfering cancer drug candidatesPARIS, April 08, 2021 (GLOBE NEWSWIRE) — Onxeo S.A. (Euronext Growth Paris: ALONX, First North Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), today announced the presentation of preclinical data confirming the differentiated antitumoral properties of the drug candidates generated by platON™, its patent-protected platform of decoy-agonists of the DNA Damage Response, in e-poster sessions during the American Association for Cancer Research (AACR 2021) virtual annual meeting on April 10, 2021. The first e-poster supports the ability of AsiDNA™, the Company’s...

Continue reading

Tricida to Present at the Needham Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 12:45 pm PT / 3:45 pm ET. Tricida will provide a company overview, business update and progress on the company’s key initiatives. A live webcast of the presentation will be accessible on the Tricida website at IR.Tricida.com. An archive of the webcast will be available for 90 days following the presentation. About Tricida Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida is currently conducting a renal outcomes clinical...

Continue reading

VINCI Shareholders’ General Meeting of 8 April 2021

Rueil Malmaison, 8 April 2021 VINCI Shareholders’ General Meeting of 8 April 2021Approval of all resolutions Dividend in respect of 2020: €2.04 per share, to be paid in cash on 22 April 2021 Renewal of the term of office as Director of Mrs Yannick Assouad, Lead Director, and of Mrs Graziella Gavezotti Shareholders’ support for the Group’s environmental ambition, a first in FranceVINCI’s Combined Shareholders General Meeting, chaired by Xavier Huillard, Chairman and Chief Executive Officer, was held on 8 April 2021 at the company’s head office in Rueil Malmaison. It took place behind closed doors due to the Covid-19 epidemic. With a 65.66% quorum, the meeting approved all the resolutions submitted, of which:the parent company and consolidated financial statements for the fiscal year ended 31 December 2020; a dividend of €2.04 per...

Continue reading

Assemblée générale des actionnaires de VINCI du 8 avril 2021

Rueil-Malmaison, le 8 avril 2021 Assemblée générale des actionnaires de VINCI du 8 avril 2021Approbation de l’ensemble des résolutions Dividende au titre de l’exercice 2020 : 2,04 euros par action, payable en numéraire le 22 avril 2021 Renouvellement des mandats d’administrateur de Mme Yannick Assouad, administrateur référent, et de Mme Graziella Gavezotti Adhésion des actionnaires à l’ambition environnementale du Groupe, une première en FranceL’assemblée générale mixte des actionnaires de VINCI s’est réunie le 8 avril 2021 au siège social de la société à Rueil-Malmaison, sous la présidence de Xavier Huillard, président-directeur général. Elle s’est tenue à huis clos en raison de l’épidémie de Covid-19. Avec un quorum de 65,66 %, l’assemblée générale a approuvé l’ensemble des résolutions qui lui étaient soumises, dont :les...

Continue reading

Delta Drone International Strengthens Board With New Appointments

8 April 2021 – Delta Drone International (ASX:DLT) (Delta Drone or the Company) is pleased to announce it has appointed Mr Christian Viguié and Mr Nicolas Clerc to the Board of Directors as non-executive directors with immediate effect. Christian is Chairman and CEO of Delta Drone SA, Delta Drone’s majority shareholder. A graduate of IEP Paris, Christian worked as a financial analyst before forming several financial reporting companies. He also served as Director General of the Unilog Group from 1998 to 2006, where he was responsible for relationships with the finance community. Nicolas is Group CFO of Delta Drone SA. Nicolas has an Advanced Degree in Accounting and Management and 20 years’ experience in accounting and audit firms including PriceWaterhouseCoopers and TEOREM. He joined the Delta Drone group in September 2017 as Group...

Continue reading

DELTA DRONE INTERNATIONAL RENFORCE SON CONSEIL D’ADMINISTRATION

Communiqué ASX 8 avril 2021 à 18h – Delta Drone International (ASX : DLT) a le plaisir d’annoncer la nomination de MM. Christian Viguié et Nicolas Clerc au Conseil d’Administration en tant qu’administrateurs non exécutifs avec effet immédiat. Christian est Président-directeur général de Delta Drone SA, actionnaire majoritaire de Delta Drone International. Diplômé de l’IEP Paris, Christian a travaillé comme analyste financier avant de créer plusieurs sociétés de conseil et d’information financière. Il a également été directeur général du groupe Unilog de 1998 à 2006, où il était responsable des relations avec la communauté financière. Nicolas est Directeur financier de Delta Drone SA. Diplômé d’études supérieures en comptabilité et gestion, Nicolas jouit de 20 ans d’expérience dans des cabinets...

Continue reading

EssilorLuxottica : Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2021

Disclosure of Share Capital and Voting Rights Outstandingas of March 31, 2021 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (April 8, 2021 – 6:00 pm) – As of March 31, 2021, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.  March 31, 2021Shares outstanding          439,022,4511Number of real voting rights (excluding treasury shares) 437,816,742Theoretical number of voting rights (including treasury shares) 439,022,451It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula...

Continue reading

EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2021

Nombre total de droits de vote et d’actionscomposant le capital social au 31 mars 2021 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton-le-Pont, France (8 avril 2021 – 18h00) –  Au 31 mars 2021, le capital d’EssilorLuxottica, le leader mondial dans la conception, la fabrication et la distribution de verres ophtalmiques, de montures et de lunettes de soleil, s’établit comme indiqué ci-dessous.  31 mars 2021Nombre total d’actions composant le capital          439 022 4511Nombre réel des droits de vote (déduction faite des actions auto détenues) 437 816 742Nombre théorique des droits de vote (y compris actions auto détenues) 439 022 451A noter, les droits de vote font l’objet d’un plafonnement à 31 % applicable à tout actionnaire conformément...

Continue reading

ABC arbitrage – droits de vote au 31 mars 2021

Information relative au nombre total de droits de vote et d’actions composant le capital social à la date du 31 mars 2021 Article L 223-16  du Règlement Général de l’Autorité des Marchés Financiers Raison sociale de l’émetteur : ABC arbitrage – 18 rue du Quatre Septembre – 75002 Paris.Nbre total d’actions composant le capital 58 512 053Total théorique des droits de vote 58 512 053Total réel des droits de vote* 58 151 380* Total réel = nombre total de droits de vote attachés au nombre total d’actions – actions privées  Pièce jointe03_2021 ABCA CP Droits de vote-mars 21 -VF

Continue reading

Euronext announces volumes for March 2021

CONTACT – Media:  CONTACT – Investor Relations:Amsterdam +31 20 721 41 33 Brussels +32 2 620 15.50 +33 1 70 48 24 17  DublinOslo +353 1 617 4249+47 22 34 17 34 LisbonParis +351 210 600 614+33 1 70 48 24 45    EURONEXT ANNOUNCES VOLUMES FOR MARCH 2021 Amsterdam, Brussels, Dublin, Lisbon, Oslo and Paris – 8 April 2021 – Euronext, the leading pan-European market infrastructure, today announced trading volumes for March 2021. Monthly and historical volume tables are available at this address: https://euronext.com/investor-relations#monthly-volumes CONTACTS media – mediateam@euronext.comAurélie Cohen (Europe/Paris) :                               +33 1 70 48 24 45                   parispressoffice@euronext.com  Marianne Aalders (Amsterdam):                                           +31 20 721 41 33                   ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.